SEARCH

SEARCH BY CITATION

References

  • 1
    Segev F, Jaeger-Roshu S, Gefen-Carmi N, Assia EI. Combined mitomycin C application and free flap conjunctival autograft in pterygium surgery. Cornea 2003;22:598603.
  • 2
    English RS, Shenefelt PD. Keloids and hypertrophic scars. Dermatol Surg 1999;25:6318.
  • 3
    Slemp AE, Kirschner RE. Keloids and scars: a review of keloids and scars, their pathogenesis, risk factors, and management. Curr Opin Pediatr 2006;18:396402.
  • 4
    Murray JC. Scars and keloids. Dermatol Clin 1993;11:697707.
  • 5
    Nemeth AJ. Keloids and hypertrophic scars. J Dermatol Surg Oncol 1993;19:73846.
  • 6
    Linares HA, Larson DL. Elastic tissue and hypertrophic scars. Burns 1976;3:407.
  • 7
    Calnan JS, Copenhagen HJ. Autotransplantation of keloid in man. Br J Surg 1967;54:3305.
  • 8
    Ehrlich HP, Desmouliere A, Diegelmann RF, et al. Morphological and immunochemical differences between keloid and hypertophic scar. Am J Pathol 1994;145:10513.
  • 9
    Blackburn WR, Cosman B. Histologic basis of keloid and hypertrophic scar differentiation. Clinicopathologic correlation. Arch Pathol 1966;82:6571.
  • 10
    Grinnell F. Fibroblasts, myofibroblasts, and wound contracture. J Cell Biol 1994;124:4014.
  • 11
    Costa AM, Peyrol S, Porto LC, et al. Mechanical forces induce scar remodeling. Study in non-pressure-treated versus pressure-treated hypertrophic scars. Am J Pathol 1999;155:16719.
  • 12
    Diegelmann RF, Cohen IK, McCoy BJ. Growth kinetics and collagen synthesis of normal skin, normal scar and keloid fibroblasts in vitro. J Cell Physiol 1979;98:3416.
  • 13
    Niessen FB, Spauwen PH, Schalkwijk J, Kon M. On the nature of hypertrophic scars and keloids: a review. Plast Reconstr Surg 1999;104:143558.
  • 14
    Nicoletis C, Bazin S, Lous ML. Clinical and biochemical features of normal, defective and pathologic scars. Clin Plast Surg 1977;4:34759.
  • 15
    Su CW, Alizadeh K, Boddie A, Lee RC. The problem scar. Clin Plast Surg 1998;25:45165.
  • 16
    Tuan TL, Nichter LS. The molecular basis of keloid and hypertrophic scar formation. Mol Med Today 1998;4:1924.
  • 17
    Bock O, Yu H, Zitron S, et al. Studies of fransforming growth factors beta 1-3 and their receptors I and II in fibroblast of keloids and hypertrophic scars. Acta Dermatol Venereol 2005;85:21620.
  • 18
    Stamenkovic I. Extracellular matrix remodelling: the role of matrix metalloproteinases. J Pathol 2003;200:44864.
  • 19
    Pearson G, Robinson F, Beers Gibson T, et al. Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocr Rev 2001;22:15383.
  • 20
    Rockwell WB, Cohen IK, Ehrlich HP. Keloids and hypertrophic scars. A comprehensive review. Plast Reconstr Surg 1989;84:82737.
  • 21
    Cohen IK, Peacock EE Jr. Keloids and hypertophic scars. In: McCarthyJG (editor). Plastic Surgery. Vol. 1. Philadelphia: Saunders. 1990. p. 73246.
  • 22
    Abergel RP, Pizzurro D, Meeker CA, et al. Biochemical composition of the connective tissue in keloids and analysis of collagen metabolism in keloid fibroblast cultures. J Invest Dermatol 1985;84:38490.
  • 23
    Friedman DW, Boyd CD, Mackenzie JW, et al. Regulation of collagen gene expression in keloids and hypertrophic scars. J Surg Res 1993;55:21422.
  • 24
    Nakaoka H, Miyauchi S, Miki Y. Proliferating activity of dermal fibroblasts in keloids and hypertrophic scars. Acta Dermatol Venereol 1995;75:1024.
  • 25
    Oliver N, Babu M, Diegelmann R. Fibronectin gene transcription is enhanced in abnormal wound healing. J Invest Dermatol 1992;99:57986.
  • 26
    Babu M, Diegelmann R, Oliver N. Fibronectin is overproduced by keloid fibroblasts during abnormal wound healing. Mol Cell Biol 1989;9:164250.
  • 27
    Chen MA, Davidson TM. Scar management: prevention and treatment strategies. Curr Opin Otolaryngol Head Neck Surg 2005;13:2427.
  • 28
    Haisa M, Okochi H, Grotendorst GR. Elevated levels of PDGF alpha receptors in keloid fibroblasts contribute to an enhanced response to PDGF. J Invest Dermatol 1994;103:5603.
  • 29
    Messadi DV, Le A, Berg S, et al. Expression of apoptosis-associated genes by human dermal scar fibroblasts. Wound Repair Regen 1999;7:5117.
  • 30
    Luo S, Benathan M, Raffoul W, et al. Abnormal balance between proliferation and apoptotic cell death in fibroblasts derived from keloid lesions. Plast Reconstr Surg 2001;107:8796.
  • 31
    Stegman SJ, Tromovitch TA, Glogau RG. Treatment of keloids. In: StegmanSJ, editor. Cosmetic Dermatologic Surgery. 2nd ed. Chicago: Year Book Medical; 1990. p. 2016.
  • 32
    Stucker FJ, Shaw GY. An approach to management of keloids. Arch Otolaryngol Head Neck Surg 1992;118:637.
  • 33
    Rudolph R. Wide spread scars, hypertrophic scars and keloids. Clin Plast Surg 1987;14:25360.
  • 34
    Davies DM. Plastic and reconstructive surgery. Scars, hypertrophic scars and keloids. Br Med J 1985;290:10568.
  • 35
    Alhady SM, Sivanantharajah K. Keloids in various races. A review of 175 cases. Plast Reconstr Surg 1969;44:5646.
  • 36
    Moustafa MF, Abdel-Fattah MA, Abdel-Fattah DC. Presumptive evidence of the effect of pregnancy estrogens on keloid growth. Plast Reconstr Surg 1975;56:4503.
  • 37
    Lanza JT, Lucente FE, Har-El G. Keloid. Otolaryngol Head Neck Surg 1992;106:7412.
  • 38
    Baisch A, Riedel F. Hyperplastic scars and keloids. Part I: basics and prevention. HNO 2006;54:893904.
  • 39
    Baisch A, Riedel F. Hyperplastic scars and keloids. Part II: surgical and non-surgical treatment modalities. HNO 2006;54:98192.
  • 40
    Sherris DA, Larrabee WF, Murakami CS. Management of scar contractures, hypertrophic scars, and keloids. Otolaryngol Clin North Am 1995;28:105768.
  • 41
    Borges AF. The W-plasty versus the Z-plasty scar revision. Plast Reconstr Surg 1969;44:5862.
  • 42
    Riedel F, Hormann K. Plastic surgery of skin defects in the face. Principles and perspectives. HNO 2005;53:102036.
  • 43
    Datubo-Brown DD. Keloids: a review of the literature. Br J Plat Surg 1990;43:707.
  • 44
    Salasche SJ, Grabski WJ. Keloids of the earlobes: a surgical technique. J Dermatol Surg Oncol 1983;9:5526.
  • 45
    Engrav LH, Gottlieb JR, Millard SP, et al. A comparison of intramarginal and extramarginal excision of hypertophic burn scars. Plast Reconstr Surg 1988;81:405.
  • 46
    Brown LA Jr, Pierce HE. Keloids: scar revision. J Dermatol Surg Oncol 1986;12:516.
  • 47
    Cosman B, Crikelair GF, Ju MC, et al. The surgical treatment of keloids. Plast Reconstr Surg 1961;27:33545.
  • 48
    Shaffer JJ, Taylor SC, Cook-Bolden F. Keloidal scars: a review with a critical look at therapeutic options. J Am Acad Dermatol 2002;46:6397.
  • 49
    Kauh YC, Rouda S, Mondragon G, et al. Major suppression of pro-alpha1(I) type I collagen gene expression in the dermis after keloid excision and immediate intrawound injection of triamcinolone acetonide. J Am Acad Dermatol 1997;37:5869.
  • 50
    Urioste SS, Arndt KA, Dover JS. Keloids and hypertrophic scars: review and treatment strategies. Semin Cutan Med Surg 1999;18:15971.
  • 51
    Linares HA, Larson DL, Willis-Galstaun BA. Historical notes on the use of pressure in the treatment of hypertrophic scars or keloids. Burns 1993;19:1721.
  • 52
    Reno F, Sabbatini M, Stella M, et al. Effect of in vitro mechanical compression on Epilysin (matrix metalloproteinase-28) expression in hypertrophic scars. Wound Repair Regen 2005;13:25561.
  • 53
    Reno F, Sabbatini M, Lombardi F, et al. In vitro mechanical compression induces apoptosis and regulates cytokines release in hypertrophic scars. Wound Repair Regen 2003;11:3316.
  • 54
    Brissett AE, Sherris DA. Scar contractures, hypertrophic scars and keloids. Facial Plast Surg 2001;17:26372.
  • 55
    Agrawal K, Panda KN, Arumugam A. An inexpensive self fabricated pressure clip for the ear lobe. Br J Plast Surg 1998;51:1223.
  • 56
    Kischer CW, Shetlar MR, Shetlar CL. Alteration of hypertrophic scars induced by mechanical pressure. Arch Dermatol 1975;111:604.
  • 57
    Gold MH. A controlled clinical trial of topical silicone gel sheeting in the treatment of hypertrophic scars and keloids. J Am Acad Dermatol 1994;30:5067.
  • 58
    Fulton JE. Silicone gel sheeting for the prevention and management of evolving hypertrophic and keloid scars. Dermatol Surg 1995;21:94751.
  • 59
    Chang CC, Kuo YF, Chiu HC, et al. Hydration, not silicone, modulates the effects of keratinocytes on fibroblasts. J Surg Res 1995;59:70511.
  • 60
    DeBeurmann R, Gougerot GH. Cheloides des musquescies. Ann Dermatol Syphilol 1906;7:151.
  • 61
    Borok TL, Bray M, Sinclair I. Role of ionizing irradiation for 393 keloids. Int J Radiat Oncol Biol Phys 1988;15:86570.
  • 62
    Cosman B, Crikelair GF, Ju DM, et al. The surgical treatment of keloids. Plast Reconstr Surg 1961;27:33558.
  • 63
    Klumpar DI, Murray JC, Anscher M. Keloids treated with excision followed by radiation therapy. J Am Acad Dermatol 1994;31:22531.
  • 64
    Kovalie JJ, Perez CA. Radiation therapy following keloidectomy: a 20-year experience. Int J Radiat Oncol Biol Phys 1989;17:7780.
  • 65
    Van Den Brenk HA, Minty CC. Radiation in the management of keloids and hypertrophic scars. Br J Surg 1960;47:595605.
  • 66
    Malaker K, Vijayraghavan K, Hodson I, Al Yafi T. Retrospective analysis of treatment of unresectable keloids with primary radiation over 25 years. Clin Oncol 2004;16:2908.
  • 67
    Alster TS. Laser treatment of hypertrophic scars, keloids and striae. Dermatol Clin 1997;15:41929.
  • 68
    Goldman MP, Fitzpatrick RE. Laser treatment of scars. Dermatol Surg 1995;21:6857.
  • 69
    Karsai S, Roos S, Hammes S, Raulin C. Pulsed dye laser: what's new in non-vascular lesions? J Eur Acad Dermatol Venereol 2007;21:87790. Review.
  • 70
    Alster TS. Improvement of erythematous and hypertophic scars by the 585-nm flashlamp-pumped pulsed dye laser. Ann Plast Surg 1994;32:18690.
  • 71
    Kuo YR, Wu WS, Jeng SF, et al. Activation of ERK and p38 kinase mediated keloid fibroblast apoptosis after flashlamp pulsed-dye laser treatment. Lasers Surg Med 2005;36:317.
  • 72
    Kuo YR, Wu WS, Jeng SF, et al. Suppressed TGF-beta1 expression is correlated with up-regulation of matrix metalloproteinase-13 in keloid regression after flashlamp pulsed-dye laser treatment. Lasers Surg Med 2005;36:3842.
  • 73
    Chan HH, Wong DS, Ho WS, et al. The use of pulsed dye laser for the prevention and treatment of hypertrophic scars in Chinese persons. Dermatol Surg 2004;30:98794.
  • 74
    Norris JE. The effect of carbon dioxide laser surgery on the recurrence of keloids. Plast Reconstr Surg 1991;87:449.
  • 75
    Apfelberg DB, Maser MR, White DN, Lash H. Failure of carbon dioxide laser excision of keloids. Lasers Surg Med 1989;9:3828.
  • 76
    Golladay ES. Treatment of keloids by single intraoperative perilesional injection of repository steroid. South Med J 1988;81:7368.
  • 77
    Goslen JB. The role of steroids in preventing scar formation. In: ThomasJR, HoltGR, editors. Facial Scars: Incisions, Revisions, and Camouflage. St. Louis: CV Mosby; 1989. p. 8397.
  • 78
    Gupta S, Kalra A. Efficacy and safety of intralesional 5-fluorouracil in the treatment of keloids. Dermatology 2002;204:1302.
  • 79
    Fitzpatrick RE. Treatment of inflamed hypertrophic scars using intralesional 5-FU. Dermatol Surg 1999;25:22432.
  • 80
    Apikian M, Goodman G. Intralesional 5-fluorouracil in the treatment of keloid scars. Australas J Dermatol 2004;45:1403.
  • 81
    Asilian A, Darougheh A, Shariati F. New combination of triamcinolone, 5-fluorouracil, and pulsed-dye laser for treatment of keloid and hypertrophic scars. Dermatol Surg 2006;32:90715.
  • 82
    Berman B, Villa A. Imiquimod 5% cream for keloid management. Dermatol Surg 2003;29:10501. Review.
  • 83
    Zurada JM, Kriegel D, Davis IC. Topical treatments for hypertrophic scars. J Am Acad Dermatol 2006;55:102431. Review.
  • 84
    Berman B, Kaufman J. Pilot study of the effect of postoperative imiquimod 5% cream on the recurrence rate of excised keloids. J Am Acad Dermatol 2002;47 (4 Suppl):20911.
  • 85
    Malhotra AK, Gupta S, Khaitan BK, Sharma VK. Imiquimod 5% cream for the prevention of recurrence after excision of presternal keloids. Dermatology 2007;215:635.
  • 86
    Augusti KT. Therapeutic values of onion (Allium cepa L.) and garlic (Allium sativum L.). Indian J Exp Biol 1996;34:63440. Review.
  • 87
    Saulis AS, Mogford JH, Mustoe TA. Effect of Mederma on hypertrophic scarring in the rabbit ear model. Plast Reconstr Surg 2002;110:17783; discussion 184–6.
  • 88
    Lee JP, Jalili RB, Tredget EE, et al. Antifibrogenic effects of liposome-encapsulated IFN-alpha2b cream on skin wounds in a fibrotic rabbit ear model. J Interferon Cytokine Res 2005;25:62731.
  • 89
    Larrabee WF, East CA, Jaffe HS, et al. Intralesional interferon gamma treatment for keloids and hypertrophic scars. Arch Otolaryngol Head Neck Surg 1990;116:115962.
  • 90
    Lu L, Saulis AS, Liu WR, et al. The temporal effects of anti-TGF-beta1,2 and 3 monoclonal antibody on wound healing and hypertrophic scar formation. J Am Coll Surg 2005;201:3917.